Annual Accounts Receivable
$5.87 M
-$726.00 K-11.01%
31 December 2023
Summary:
Cartesian Therapeutics annual accounts receivable is currently $5.87 million, with the most recent change of -$726.00 thousand (-11.01%) on 31 December 2023. During the last 3 years, it has fallen by -$1.35 million (-18.74%). RNAC annual accounts receivable is now -40.79% below its all-time high of $9.91 million, reached on 01 December 2021.RNAC Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$4.83 M
-$27.21 M-84.93%
01 September 2024
Summary:
Cartesian Therapeutics quarterly accounts receivable is currently $4.83 million, with the most recent change of -$27.21 million (-84.93%) on 01 September 2024. Over the past year, it has dropped by -$69.00 thousand (-1.41%). RNAC quarterly accounts receivable is now -84.93% below its all-time high of $32.04 million, reached on 30 June 2024.RNAC Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.0% | -1.4% |
| 3 y3 years | -18.7% | -34.1% |
| 5 y5 years | +100.0% | - |
RNAC Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -40.8% | at low | -84.9% | +140.7% |
| 5 y | 5 years | -40.8% | -84.9% | ||
| alltime | all time | -40.8% | -84.9% |
Cartesian Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.83 M(-84.9%) |
| June 2024 | - | $32.04 M(+1497.2%) |
| Mar 2024 | - | $2.01 M(-65.8%) |
| Dec 2023 | $5.87 M(-11.0%) | $5.87 M(+19.8%) |
| Sept 2023 | - | $4.90 M(-9.0%) |
| June 2023 | - | $5.38 M(-21.3%) |
| Mar 2023 | - | $6.84 M(+3.7%) |
| Dec 2022 | $6.60 M(-33.5%) | - |
| Dec 2022 | - | $6.60 M(-4.8%) |
| Sept 2022 | - | $6.92 M(-71.1%) |
| June 2022 | - | $23.99 M(+235.4%) |
| Mar 2022 | - | $7.15 M(-27.8%) |
| Dec 2021 | $9.91 M | $9.91 M(+35.4%) |
| Sept 2021 | - | $7.32 M(-13.5%) |
| June 2021 | - | $8.46 M(+1.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $8.34 M(+15.5%) |
| Dec 2020 | $7.22 M(+44.5%) | $7.22 M(-42.8%) |
| Sept 2020 | - | $12.63 M(>+9900.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $5.00 M(>+9900.0%) | $5.00 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2018 | - | $52.00 K(>+9900.0%) |
| Sept 2017 | - | $0.00(-100.0%) |
| June 2017 | - | $1000.00(-98.4%) |
| Mar 2017 | - | $63.00 K(-70.7%) |
| Dec 2016 | $215.00 K(-73.9%) | $215.00 K(-55.5%) |
| Sept 2016 | - | $483.00 K(-75.4%) |
| June 2016 | - | $1.96 M(+20.5%) |
| Mar 2016 | - | $1.63 M(+97.5%) |
| Dec 2015 | $824.00 K(+22.3%) | $824.00 K |
| Dec 2014 | $674.00 K | - |
FAQ
- What is Cartesian Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual accounts receivable year-on-year change?
- What is Cartesian Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly accounts receivable year-on-year change?
What is Cartesian Therapeutics annual accounts receivable?
The current annual accounts receivable of RNAC is $5.87 M
What is the all time high annual accounts receivable for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual accounts receivable is $9.91 M
What is Cartesian Therapeutics annual accounts receivable year-on-year change?
Over the past year, RNAC annual accounts receivable has changed by -$726.00 K (-11.01%)
What is Cartesian Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of RNAC is $4.83 M
What is the all time high quarterly accounts receivable for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly accounts receivable is $32.04 M
What is Cartesian Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, RNAC quarterly accounts receivable has changed by -$69.00 K (-1.41%)